Regeneron Pharmaceuticals (REGN) Ownership

REGN$947.05+30.99 +3.38%
BiotechnologyLarge CapHigh Quality
Compare
Market cap$97.95BEnterprise value$94.85BRevenue (TTM)$16.90BMarket positionTop 25%

Score

58
Neutral
Value
53
Quality
69
Growth
52

Institutions holding: 1.40K. Ownership 89.28%.

HolderSharesChange %
BLACKROCK, INC.9.11M+1.85%
VANGUARD CAPITAL MANAGEMENT LLC6.63M-0.38%
DODGE & COX4.87M+9.26%
STATE STREET CORP4.83M+3.65%
INVESCO LTD.3.94M+80.71%
JPMORGAN CHASE & CO3.77M-12.47%
VANGUARD PORTFOLIO MANAGEMENT LLC3.18M+84.53%
FRANKLIN TEMPLETON INC2.77M+1.83%
GEODE CAPITAL MANAGEMENT, LLC2.63M+0.69%
NUVEEN, LLC2.02M-2.18%
LOOMIS SAYLES & CO L P1.86M-2.78%
PRICE T ROWE ASSOCIATES INC /MD/1.53M-29.75%
MORGAN STANLEY1.40M+5.94%
BANK OF AMERICA CORP /DE/1.29M+8.53%
WELLINGTON MANAGEMENT GROUP LLP1.27M-30.88%
NORGES BANK1.17M—
GOLDMAN SACHS GROUP INC1.16M-10.56%
AQR CAPITAL MANAGEMENT LLC1.13M-8.52%
AMUNDI1.01M+0.37%
NORTHERN TRUST CORP916.47K-2.70%
CHARLES SCHWAB INVESTMENT MANAGEMENT INC846.31K+5.20%
SIXTH STREET PARTNERS MANAGEMENT COMPANY, L.P.846.31K—
FMR LLC831.96K-45.20%
CAPITAL WORLD INVESTORS814.92K-42.57%
LEGAL & GENERAL GROUP PLC759.97K+3.81%

Regeneron Pharmaceuticals (REGN) Ownership

REGN price $947.05 +30.99 +3.38%

Ticker
REGN
Price
$947.05
Change
+30.99 +3.38%
Market cap
$97.95B
P/E
19.67
Forward P/E
11.46
Dividend yield
0.40%
Beta
0.24
Sector
Healthcare
Industry
Biotechnology
Stocklytics score
58
Value
53
Quality
69
Growth
52

Stocklytics score rationale: value 53, quality 69, growth 52.

AI Score 85. Regeneron Pharmaceuticals, Inc. has a strong market cap of approximately $95.5 billion and impressive profit margins, with a net profit margin of 28.5%

Fair value

REGN fair value $1,647.42. Price $947.05. Price is 43% below fair value.

Below fair value, and cheaper than usual. A larger discount than on 64% of days in the past 5 years.

Fair value is an estimate of what one share is worth if future cash flows arrive as modeled. It is not a forecast of the share price.

Fair value blends a 10-year DCF and an earnings multiple: the average of the DCF value and an earnings value from next-twelve-months EPS times 23.3, a blend of the Biotechnology median (28.7) and the stock's own 10-year median (17.9). How we calculate it →

Compare REGN

Earnings

DateEPS actualEPS estimateRevenueRevenue estimate
2027-01-28—25.39—5.85B
2026-10-3020.0716.515.12B4.58B
2026-07-3014.2910.164.29B3.82B
2026-04-299.478.913.61B3.48B
2026-01-3011.4410.743.88B3.81B
2025-10-2811.839.653.75B3.59B
2025-08-0112.898.433.68B3.29B
2025-04-298.228.623.03B3.25B
2025-02-0412.0711.213.79B3.74B
2024-10-3112.4611.693.72B3.67B
2024-08-0111.5610.613.55B3.38B
2024-05-029.5510.173.15B3.23B
2024-02-0211.8610.733.43B3.29B
2023-11-0211.5910.723.36B3.22B
2023-08-0310.249.843.16B3.02B
2023-05-0410.099.253.16B3.00B
2023-02-0312.5610.033.41B3.12B
2022-11-0311.149.482.94B2.92B
2022-08-039.778.532.86B2.79B
2022-05-048.939.742.97B2.69B
2022-02-0421.3218.354.95B4.56B
2021-11-0414.3710.103.45B2.69B
2021-08-0525.8017.535.14B3.92B
2021-05-069.899.002.53B2.65B
2021-02-059.538.392.42B2.46B
2020-11-058.367.142.29B301.49M
2020-08-057.165.981.95B1.63B
2020-05-056.606.131.83B1.70B
2020-02-067.506.912.17B2.00B
2019-11-056.676.362.05B1.95B
2019-08-066.025.421.93B1.42B
2019-05-074.455.471.71B1.69B
2019-02-066.845.601.93B1.58B
2018-11-065.875.131.66B1.45B
2018-08-025.454.701.61B1.39B
2018-05-034.674.351.51B1.41B
2018-02-085.234.681.58B1.37B
2017-11-083.993.851.50B1.45B
2017-08-034.173.171.47B1.12B
2017-05-042.923.061.32B1.38B

Dividends

Yield 0.39%. Payout ratio 7.95%. Frequency Quarterly.

Safety score 72/100 · Moderate. Payout ratio is 8% of earnings. Dividends use less than 40% of free cash flow. Dividend history is short. Yield is 0.4%, which is low.

Ex-dateDividendRecordPaymentFrequency
2026-11-20$0.942026-11-202026-12-03Quarterly
2026-08-18$0.942026-08-182026-08-31Quarterly
2026-05-20$0.942026-05-202026-06-04Quarterly
2026-02-20$0.942026-02-202026-03-05Quarterly
2025-11-20$0.882025-11-202025-12-05Quarterly
2025-08-18$0.882025-08-182025-09-03Quarterly
2025-05-20$0.882025-05-202025-06-06Quarterly
2025-02-20$0.882025-02-202025-03-20Quarterly

Insider trades

DateInsiderActionSharesPriceValue
2026-11-04Pitofsky JasonBuy905$492.00445.26K
2026-11-04Pitofsky JasonSell439$939.57412.47K
2026-11-04Pitofsky JasonBuy1.48K$644.54952.63K
2026-11-04Pitofsky JasonSell575$940.46540.76K
2026-11-04Pitofsky JasonSell982$941.58924.63K
2026-11-04Pitofsky JasonBuy1.50K$726.531.09M
2026-11-04Pitofsky JasonSell1.22K$942.311.14M
2026-11-04Pitofsky JasonSell529$943.53499.13K
2026-11-04Pitofsky JasonSell108$944.22101.98K
2026-11-04Pitofsky JasonSell35$945.6133.10K
2026-11-04Pitofsky JasonSell1.50K$726.531.09M
2026-11-04Pitofsky JasonSell1.48K$644.54952.63K
2026-11-04Pitofsky JasonSell905$492.00445.26K
2026-11-04Pitofsky JasonSell179$950.76170.19K
2026-11-03MURPHY ANDREW JSell1.05K——
2026-11-03Zoghbi Huda YBuy7.44K$380.952.83M
2026-11-03Zoghbi Huda YSell6.94K$970.426.73M
2026-11-03Zoghbi Huda YSell500$971.06485.53K
2026-11-03Zoghbi Huda YSell7.44K$380.952.83M
2026-11-02SING GEORGE LBuy7.44K$380.952.83M
2026-11-02SING GEORGE LSell1.22K$960.571.18M
2026-11-02SING GEORGE LSell540$961.85519.40K
2026-11-02SING GEORGE LSell2.52K$962.612.43M
2026-11-02SING GEORGE LBuy7.83K$376.692.95M
2026-11-02SING GEORGE LSell4.34K$963.474.18M
2026-11-02SING GEORGE LSell2.67K$964.572.58M
2026-11-02SING GEORGE LSell7.07K$965.386.83M
2026-11-02SING GEORGE LSell1.52K$966.271.47M
2026-11-02SING GEORGE LSell1.04K$967.071.01M
2026-11-02SING GEORGE LSell200$970.18194.04K
2026-11-02SING GEORGE LSell7.83K$376.692.95M
2026-11-02SING GEORGE LSell7.44K$380.952.83M
2026-11-02POON CHRISTINE ABuy7.83K$376.692.95M
2026-11-02POON CHRISTINE ASell218$966.74210.75K
2026-11-02POON CHRISTINE ASell772$967.38746.82K
2026-11-02POON CHRISTINE ASell2.50K$968.582.42M
2026-11-02POON CHRISTINE ASell3.20K$969.503.11M
2026-11-02POON CHRISTINE ASell937$970.51909.37K
2026-11-02POON CHRISTINE ASell201$971.31195.23K
2026-11-02POON CHRISTINE ASell7.83K$376.692.95M
2026-11-02Fenimore Christopher R.Buy6.00K$381.922.29M
2026-11-02Fenimore Christopher R.Sell4.24K$950.504.03M
2026-11-02Fenimore Christopher R.Sell15——
2026-11-02Fenimore Christopher R.Sell6.00K$381.922.29M
2026-11-02LAROSA JOSEPH JBuy12.28K$381.924.69M
2026-11-02LAROSA JOSEPH JSell8.69K$950.508.26M
2026-11-02LAROSA JOSEPH JSell3.94K$965.413.80M
2026-11-02LAROSA JOSEPH JSell527$966.11509.14K
2026-11-02LAROSA JOSEPH JSell12.28K$381.924.69M
2026-10-30Guarini KathrynBuy400$719.37287.75K
2026-10-30Guarini KathrynSell400$719.37287.75K
2026-10-30Guarini KathrynSell400$900.00360.00K
2026-10-30BROWN MICHAEL SBuy1.93K$725.891.40M
2026-10-30BROWN MICHAEL SSell1.93K$875.001.69M
2026-10-30BROWN MICHAEL SSell1.93K$725.891.40M
2026-10-30McCourt MarionSell1.13K$869.43984.19K
2026-10-14MURPHY ANDREW JSell6$753.764.52K
2026-10-14MURPHY ANDREW JSell35$755.9126.46K
2026-10-14MURPHY ANDREW JSell16$757.6812.12K
2026-10-14MURPHY ANDREW JSell24$758.1618.20K
2026-10-14MURPHY ANDREW JSell14$759.9610.64K
2026-10-14MURPHY ANDREW JSell74$760.6556.29K
2026-10-14MURPHY ANDREW JSell27$761.3620.56K
2026-10-14MURPHY ANDREW JSell55$762.5741.94K
2026-10-14MURPHY ANDREW JSell25$763.7619.09K
2026-10-14MURPHY ANDREW JSell219$764.40167.40K
2026-10-14MURPHY ANDREW JSell271$765.39207.42K
2026-10-14MURPHY ANDREW JSell279$766.47213.85K
2026-10-14MURPHY ANDREW JSell192$767.39147.34K
2026-10-14MURPHY ANDREW JSell105$768.3380.67K
2026-10-14MURPHY ANDREW JSell127$769.3097.70K
2026-10-14MURPHY ANDREW JSell12$770.209.24K
2026-10-14MURPHY ANDREW JSell283$771.56218.35K
2026-10-14MURPHY ANDREW JSell211$772.56163.01K
2026-10-14MURPHY ANDREW JSell224$773.40173.24K
2026-10-14MURPHY ANDREW JSell121$774.4893.71K
2026-10-14MURPHY ANDREW JSell376$775.46291.57K
2026-10-14MURPHY ANDREW JSell66$776.3151.24K
2026-10-14MURPHY ANDREW JSell38$777.7629.55K
2026-10-14MURPHY ANDREW JSell454$778.64353.50K
2026-10-14MURPHY ANDREW JSell380$779.59296.24K
2026-10-14MURPHY ANDREW JSell463$780.63361.43K
2026-10-14MURPHY ANDREW JSell50$781.4739.07K
2026-10-13MURPHY ANDREW JBuy17.00K$381.926.49M
2026-10-13MURPHY ANDREW JSell12.85K$754.589.70M
2026-10-13MURPHY ANDREW JSell17.00K$381.926.49M
2026-09-03McCourt MarionSell1.13K$857.39969.71K
2026-09-02McCourt MarionSell1.22K$850.001.03M
2026-09-02Guarini KathrynSell400$719.37287.75K
2026-09-02Guarini KathrynBuy400$719.37287.75K
2026-09-02Guarini KathrynSell400$850.00340.00K
2026-08-19LAROSA JOSEPH JBuy12.28K$381.924.69M
2026-08-19LAROSA JOSEPH JSell9.02K$830.157.49M
2026-08-19LAROSA JOSEPH JSell12.28K$381.924.69M
2026-08-18Fenimore Christopher R.Buy6.28K$381.922.40M
2026-08-18Fenimore Christopher R.Sell4.60K$813.473.74M
2026-08-18Fenimore Christopher R.Sell6.28K$381.922.40M
2026-08-10Guarini KathrynSell400$719.37287.75K
2026-08-10Guarini KathrynBuy400$719.37287.75K
2026-08-10Guarini KathrynSell400$800.00320.00K

Institutional holders

Latest filed quarter: Q2 2026.

Institutions holding: 1.40K, holders -66 vs prior quarter. Ownership 89.28%.

HolderSharesChangeChange %Value
BLACKROCK, INC.9.11M165.77K+1.85%5.68B
VANGUARD CAPITAL MANAGEMENT LLC6.63M-25.15K-0.38%4.13B
DODGE & COX4.87M412.90K+9.26%3.04B
STATE STREET CORP4.83M170.21K+3.65%3.01B
INVESCO LTD.3.94M1.76M+80.71%2.46B
JPMORGAN CHASE & CO3.77M-537.61K-12.47%2.38B
VANGUARD PORTFOLIO MANAGEMENT LLC3.18M1.45M+84.53%1.98B
FRANKLIN TEMPLETON INC2.77M49.77K+1.83%1.73B
GEODE CAPITAL MANAGEMENT, LLC2.63M18.08K+0.69%1.63B
NUVEEN, LLC2.02M-45.09K-2.18%1.26B
LOOMIS SAYLES & CO L P1.86M-53.14K-2.78%1.16B
PRICE T ROWE ASSOCIATES INC /MD/1.53M-647.82K-29.75%953.84M
MORGAN STANLEY1.40M78.38K+5.94%871.53M
BANK OF AMERICA CORP /DE/1.29M101.47K+8.53%805.02M
WELLINGTON MANAGEMENT GROUP LLP1.27M-567.37K-30.88%791.95M
NORGES BANK1.17M1.17MNew731.29M
GOLDMAN SACHS GROUP INC1.16M-137.37K-10.56%725.30M
AQR CAPITAL MANAGEMENT LLC1.13M-104.93K-8.52%702.16M
AMUNDI1.01M3.74K+0.37%631.98M
NORTHERN TRUST CORP916.47K-25.47K-2.70%571.45M
CHARLES SCHWAB INVESTMENT MANAGEMENT INC846.31K41.80K+5.20%527.71M
SIXTH STREET PARTNERS MANAGEMENT COMPANY, L.P.846.31K846.31KNew527.71M
FMR LLC831.96K-686.23K-45.20%518.76M
CAPITAL WORLD INVESTORS814.92K-604.08K-42.57%508.14M
LEGAL & GENERAL GROUP PLC759.97K27.92K+3.81%473.87M

Insights · Dividends · Forecast · Financials · Learn

Stocklytics home · Screener